Product Information

CARVEDILOL 6.25 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0181 per EA under NDC 76385011150. Its NADAC has been published 514 times since Oct 19, 2016.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Carvedilol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CARVEDILOL 6.25 MG TABLET

Carvedilol
$0.0181per EA
High Outlier

Strength

6.25 mg/1

NDC

76385011150

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078384

FDA Approved

9/5/2007

TE Code

AB

On Market Since

10/1/2016

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 6.25 MG TABLET has been published 514 times since Oct 19, 2016, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0181 per EA
All-time high$0.0281 (Sep 12, 2018)
All-time low$0.0155 (Nov 20, 2024)
52-week high$0.0187
52-week low$0.0181
Median price$0.0224
Average price$0.0223
Largest weekly change-21.2% (Nov 20, 2024)
Weeks tracked514
Tracking sinceOct 19, 2016

Price History

1W

-1.5%

1M

-1.5%

3M

-3.1%

6M

-2.1%

1Y

-3.4%

3Y

-11.6%

5Y

-20.2%

All

-35.2%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARVEDILOL 6.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 6.25 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0181 per EA (NDC 76385011150), effective Aug 19, 2026.

How has the price of CARVEDILOL 6.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 6.25 MG TABLET has declined 35.2%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 6.25 MG TABLET?

Since Oct 19, 2016, the NADAC for CARVEDILOL 6.25 MG TABLET has ranged from a low of $0.0155 (Nov 20, 2024) to a high of $0.0281 (Sep 12, 2018), with a median of $0.0224 per EA.

Are there cheaper alternatives to CARVEDILOL 6.25 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 6.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 6.25 MG TABLET?

CARVEDILOL 6.25 MG TABLET (NDC 76385011150) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.